| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.03 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.03 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.03 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.03 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.03 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.04 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.079 | 0.04 |